Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
The New England Journal of Medicine
|
July 25, 2019
Bad to the Bone
Jennifer L Crombie, Ramkumar Venkateswaran, Annette S Kim, et al.
American Journal of Hematology
|
November 15, 2021
Monotypic plasmacytoid cells mimicking lymph node malignancy in the setting of COVID-19 recovery
Mark G Evans, Anthony Crymes, Jennifer L Crombie, et al.
Plos One
|
July 19, 2018
Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility
Jeffrey W Craig, Michael J Mina, Jennifer L Crombie, et al.
Leukemia & Lymphoma
|
July 16, 2024
Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma
Jennifer L Crombie, Monika Jun, Tongsheng Wang, et al.
American Journal of Hematology
|
December 20, 2021
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia
Matthew S Davids, Mazyar Shadman, Sameer A Parikh, et al.
Haematologica
|
August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax
Fen Zhu, Jennifer L Crombie, Wei Ni, et al.
Blood Advances
|
September 2, 2021
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma
Jennifer L Crombie, Loretta J Nastoupil, Robert Redd, et al.
Blood Advances
|
March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
Sushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.
Transplantation and Cellular Therapy
|
March 11, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients
Muneerah M Aleissa, Jessica S Little, Sonya Davey, et al.
Haematologica
|
June 1, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Jennifer L Crombie, Caron A Jacobson, Robert Redd, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
The New England Journal of Medicine
|
July 25, 2019
Bad to the Bone
Jennifer L Crombie, Ramkumar Venkateswaran, Annette S Kim, et al.
American Journal of Hematology
|
November 15, 2021
Monotypic plasmacytoid cells mimicking lymph node malignancy in the setting of COVID-19 recovery
Mark G Evans, Anthony Crymes, Jennifer L Crombie, et al.
Plos One
|
July 19, 2018
Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility
Jeffrey W Craig, Michael J Mina, Jennifer L Crombie, et al.
Leukemia & Lymphoma
|
July 16, 2024
Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma
Jennifer L Crombie, Monika Jun, Tongsheng Wang, et al.
American Journal of Hematology
|
December 20, 2021
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia
Matthew S Davids, Mazyar Shadman, Sameer A Parikh, et al.
Haematologica
|
August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax
Fen Zhu, Jennifer L Crombie, Wei Ni, et al.
Blood Advances
|
September 2, 2021
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma
Jennifer L Crombie, Loretta J Nastoupil, Robert Redd, et al.
Blood Advances
|
March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
Sushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.
Transplantation and Cellular Therapy
|
March 11, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients
Muneerah M Aleissa, Jessica S Little, Sonya Davey, et al.
Haematologica
|
June 1, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Jennifer L Crombie, Caron A Jacobson, Robert Redd, et al.
Page
of 6